Healing Stigma Through Stories
Healing Stigma Through Stories: Learning From International Practices to Develop and Evaluate a Narrative Program for Individuals With Schizophrenia
This study is the first phase of the research project. The purpose of this phase is to develop and refine a narrative-based intervention designed to reduce self-stigma among people with schizophrenia.
A small pilot study will be conducted with 24 participants recruited from halfway houses in northern Taiwan. Eligible participants will receive the intervention, which consists of four group sessions and four individual sessions, held once a week for a total of eight weeks. The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma. Participants will complete a workbook during the program, and the written content will be analyzed to better understand their experiences with stigma. Any personal information will be removed to protect participants' privacy. Before and after the intervention, participants will complete questionnaires on self-stigma, depression, social functioning, well-being, hope, and recovery. Information on medication use will also be collected. Group and individual sessions will be audio-recorded for research purposes. The questionnaire data and recordings will be used to evaluate the feasibility and preliminary effects of the intervention.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: Li-Ting Huang, phD
- Telefonnummer: +8862-28267284
- E-post: lthuang@nycu.edu.tw
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Aged 18 years or older.
- Diagnosed with schizophrenia or schizoaffective disorder.
- Clinically stable at the time of study enrollment.
- Able to communicate in Mandarin Chinese or Taiwanese.
- Able to read and write and complete study questionnaires.
Exclusion Criteria:
- Individuals who lack the capacity to provide informed consent. Decision-making capacity will be assessed using a 10-item true/false questionnaire adapted from Okoli et al. (2018). Participants who answer fewer than 7 questions correctly will be excluded. Those who answer 7 or more questions correctly will receive an additional explanation from the research team. Only individuals who demonstrate a complete understanding of the study after this explanation will be enrolled.
- Unwilling to have the intervention sessions audio-recorded.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Healing Stigma through Stories
|
Four group sessions and four individual sessions, held once a week for a total of eight weeks.
The program uses narrative therapy techniques to help participants explore their personal experiences and reduce self-stigma.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
The Internalized Stigma of Mental Illness Scale
Tidsramme: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Beck Depression Inventory-II
Tidsramme: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
|
Self-Reported Graphic version of the Personal and Social Performance Scale
Tidsramme: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
|
Subjective Happiness Scale
Tidsramme: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
|
Herth Hope Index
Tidsramme: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
|
The questionnaire about the process of recovery
Tidsramme: At baseline(T0) and through study completion, an average of 8 weeks
|
At baseline(T0) and through study completion, an average of 8 weeks
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- NYCU115040AF
- 115-2314-B-A49 -082 - (Annet stipend/finansieringsnummer: National Science and Technology Council)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .